(RTTNews) - Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company, announced that five abstracts have been accepted for presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2026, being held November 5 - 9, 2026.
Aligos Therapeutics To Present HBV, HDV Programs At AASLD 2026
(RTTNews) - Aligos Therapeutics, Inc. (ALGS), a clinical-stage biopharmaceutical company, announced that five abstracts ...
By Dhallo News · October 6, 2026 at 10:55 AM IST
Have feedback on this article?Report error or suggestion
